News
R&D Company from Obninsk to Get RUR94.55 million to Finance Clinical Research
Medbiopharm R&D company, Obninsk, concluded two contracts with government agencies to carry our R&D works under Development of Pharmaceutical and Medical Industry of the Russian Federation till 2020 and Thereafter federal target program.
The validity term of these two contracts concluded under the afore-mentioned target program is two years. Under the contracts. During this period Medbiopharm plans to hold clinical trials of two pharmaceuticals: a medicine to cure male and female infertility, which restores spermatogenesis regenerative potential and improves fertility, as well as a medicine to cure influenza, which suppresses the virus reproduction through inhibiting virus cell penetration and inducing interferon synthesis. The total amount of budget financing under two contracts equals RUR 94,550,000: RUR47,550,000 and RUR 47,000,000 correspondingly.
15.07.2013
Share in
Other news
Investment digest
Printed products
Production placement application
Establishment of industrial parks with high quality sites with all relevant utilities for new plants construction ensures well-balanced distribution of industrial facilities throughout the region with due consideration of transport, utilities and social infrastructure development and future labor resources development.
If you are interested in placement of a production facility at an investment site, please fill in the online application form.
Thank you!
You successfully subscribed to news digest
Thank you!
Your message has been sent.
error
Error!